Shuaikang Pan

机构：Wannan Medical College, University of Science and Technology of China

发表论文 13 篇 · 总被引 166 次 · h-index 6

代表论文

• Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment (2025 · Molecular Cancer · 被引 65)
• Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice (2022 · Frontiers in Immunology · 被引 35)
• Systematic Investigation of the Multifaceted Role of SOX11 in Cancer (2022 · Cancers · 被引 15)
• Combination of Immune-Related Network and Molecular Typing Analysis Defines a Three-Gene Signature for Predicting Prognosis of Triple-Negative Breast Cancer (2022 · Biomolecules · 被引 15)
• Increased ACSL6 Expression Predicts a Favorable Prognosis in Triple-negative Breast Cancer (2024 · Current Medicinal Chemistry · 被引 14)
• LCP1 correlates with immune infiltration: a prognostic marker for triple-negative breast cancer (2024 · BMC Immunology · 被引 10)